Követés
D.M.W. Balak, MD PhD MSc
D.M.W. Balak, MD PhD MSc
Dermatologist at Leiden University Medical Center
E-mail megerősítve itt: lumc.nl
Cím
Hivatkozott rá
Hivatkozott rá
Év
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
E Hajdarbegovic, DM Balak
The New England journal of medicine 376 (21), 2092, 2017
604*2017
A benchmark for comparison of cell tracking algorithms
M Maška, V Ulman, D Svoboda, P Matula, P Matula, C Ederra, A Urbiola, ...
Bioinformatics 30 (11), 1609-1617, 2014
4762014
Drug-induced psoriasis: clinical perspectives
DMW Balak, E Hajdarbegovic
Psoriasis (Auckland, NZ) 7, 87, 2017
1592017
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
DS Bakker, LFM Ariens, C van Luijk, J van der Schaft, JL Thijs, ...
British Journal of Dermatology, 2018
1232018
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe …
DMW Balak, MBA van Doorn, RD Arbeit, R Rijneveld, E Klaassen, ...
Clinical Immunology 174, 63-72, 2017
962017
In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine
M Xu, J Deng, K Xu, T Zhu, L Han, Y Yan, D Yao, H Deng, D Wang, Y Sun, ...
THERANOSTICS 9 (9), 2475-2488, 2019
862019
Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic review
DMW Balak, GJD Hengstman, A Çakmak, HB Thio
Multiple Sclerosis Journal 18 (12), 1705-1717, 2012
812012
Fumaric acid esters in the management of psoriasis
DMW Balak
Psoriasis Targets Ther 5, 9-23, 2015
572015
Tissue‐resident memory CD8+ T cells from skin differentiate psoriatic arthritis from psoriasis
EF Leijten, TS van Kempen, MA Olde Nordkamp, JN Pouw, ...
Arthritis & Rheumatology, 0
53
Refinement of the genetic cause of ATR-16
CL Harteveld, M Kriek, EK Bijlsma, Z Erjavec, D Balak, M Phylipsen, ...
Human genetics 122 (3-4), 283-292, 2007
462007
Efficacy, effectiveness and safety of fumaric acid esters in the treatment of psoriasis: a systematic review of randomized and observational studies
DMW Balak, S Fallah Arani, E Hajdarbegovic, CAF Hagemans, ...
British Journal of Dermatology 175 (2), 250-262, 2016
422016
Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands
DMW Balak, AM Oostveen, MT Bousema, AW Venema, WP Arnold, ...
British Journal of Dermatology 168 (6), 1343-1347, 2013
422013
Long-term safety and effectiveness of high-dose dimethylfumarate in the treatment of moderate to severe psoriasis: a prospective single-blinded follow-up study
R Lijnen, E Otters, D Balak, B Thio
Journal of Dermatological Treatment 27 (1), 31-36, 2016
362016
Regulated genes in psoriatic skin during treatment with fumaric acid esters
AJ Onderdijk, DMW Balak, EM Baerveldt, EF Florencia, M Kant, JD Laman, ...
British Journal of Dermatology 171 (4), 732-741, 2014
362014
Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis
R Achten, D Bakker, L Ariens, A Lans, J Thijs, J van der Schaft, J de Boer, ...
The Journal of Allergy and Clinical Immunology: In Practice, 2020
352020
Prenatal diagnosis for haemophilia: a nationwide survey among female carriers in the Netherlands
DMW Balak, SC Gouw, I Plug, EP MAUSER‐BUNSCHOTEN, A Vriends, ...
Haemophilia 18 (4), 584-592, 2012
302012
Prenatal diagnosis for haemophilia: a nationwide survey among female carriers in the Netherlands
DMW Balak, SC Gouw, I Plug, EP Mauser-Bunschoten, A Vriends, ...
HAEMOPHILIA 17 (2), 367-368, 2011
302011
Highlights of the updated Dutch evidence-and consensus-based guideline on psoriasis 2017.
GE van der Kraaij, DMW Balak, CI Busard, OD van Cranenburgh, ...
The British journal of dermatology 180 (1), 31, 2019
272019
Is mipomersen ready for clinical implementation? A transatlantic dilemma
B Sjouke, DMW Balak, U Beuers, V Ratziu, ESG Stroes
Current opinion in lipidology 24 (4), 301-306, 2013
262013
Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies
DMW Balak, S Piaserico, I Kasujee
Psoriasis: Targets and Therapy 11, 151, 2021
222021
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20